| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316276 | Pancreatology | 2016 | 8 Pages |
Abstract
Interleukin-6 appears to be implicated in the development of chronic hyperglycemia and insulin resistance in patients after acute pancreatitis. It may become a potential target in the prevention and early treatment of diabetes after diseases of the exocrine pancreas.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Nicola Gillies, Sayali A. Pendharkar, Varsha M. Asrani, Juby Mathew, John A. Windsor, Maxim S. Petrov,